1
Total investments
0
Early stage
0
Mid stage
1
Late stage
4y
Years active
Experience · 2 entries
All (2)
Investments (1)
Founder (1)
2022
Seed Investor
Sep 2022
Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition.
2020